{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:27:56Z","timestamp":1793316476815,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T00:00:00Z","timestamp":1490227200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","valueinhealthjournal.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.jval.2016.11.016","type":"journal-article","created":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T13:46:08Z","timestamp":1486647968000},"page":"662-669","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":669,"title":["Estimating an EQ-5D-5L Value Set for China"],"prefix":"10.1016","volume":"20","author":[{"given":"Nan","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haijing","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Rand-Hendriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jval.2016.11.016_bib1","series-title":"Evaluation of Health Care Programmes","article-title":"Methods for the Economic","author":"Drummond","year":"1997"},{"key":"10.1016\/j.jval.2016.11.016_bib2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s40273-014-0136-z","article-title":"Estimating QALY gains in applied studies: a review of cost-utility analyses published in 2010","volume":"32","author":"Wisloff","year":"2014","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jval.2016.11.016_bib3","series-title":"EQ-5D Value Sets: Inventory, Comparative Review and User Guide","author":"Szende","year":"2007"},{"key":"10.1016\/j.jval.2016.11.016_bib4","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1007\/s11136-011-9903-x","article-title":"Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L)","volume":"20","author":"Herdman","year":"2011","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jval.2016.11.016_bib5","author":"Devlin","year":"2016","journal-title":"Valuing health-related quality of life: an EQ-5D-5L value set for England."},{"key":"10.1016\/j.jval.2016.11.016_bib6","first-page":"47","article-title":"Developing a Japanese version of the EQ-5D-5L value set","volume":"64","author":"Ikeda","year":"2015","journal-title":"J Natl Inst Public Health"},{"key":"10.1016\/j.jval.2016.11.016_bib7","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/MLR.0000000000000447","article-title":"A time trade-off-derived value set of the EQ-5D-5L for Canada","volume":"54","author":"Xie","year":"2016","journal-title":"Med Care"},{"key":"10.1016\/j.jval.2016.11.016_bib8","doi-asserted-by":"crossref","first-page":"A810","DOI":"10.1016\/j.jval.2015.09.104","article-title":"An EQ-5D-5L value set based on Uruguayan population preferences: report of the first experience in Latin America","volume":"18","author":"Augustovski","year":"2015","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2016.11.016_bib9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jval.2016.01.003","article-title":"Dutch tariff for the five-level version of EQ-5D","volume":"19","author":"Versteegh","year":"2016","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2016.11.016_bib10","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1007\/s11136-015-1205-2","article-title":"The EQ-5D-5L valuation study in Korea","volume":"25","author":"Kim","year":"2016","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jval.2016.11.016_bib11","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1007\/s11136-012-0342-0","article-title":"A comparison of the scaling properties of the English, Spanish, French, and Chinese EQ-5D descriptive systems","volume":"22","author":"Luo","year":"2013","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jval.2016.11.016_bib12","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1007\/s11136-014-0670-3","article-title":"Comparison between the EQ-5D-5L and the EQ-5D-3L in patients with hepatitis B","volume":"23","author":"Jia","year":"2014","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jval.2016.11.016_bib13","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1007\/s11136-014-0902-6","article-title":"The EQ-5D-5L index score is more discriminative than the EQ-5D-3L index score in diabetes patients","volume":"24","author":"Pan","year":"2015","journal-title":"Qual Life Res"},{"key":"10.1016\/j.jval.2016.11.016_bib14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jval.2014.04.002","article-title":"A program of methodological research to arrive at the new international EQ-5D-5L valuation protocol","volume":"17","author":"Oppe","year":"2014","journal-title":"Value Health"},{"key":"10.1016\/j.jval.2016.11.016_bib15","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/hec.2819","article-title":"A comparison of alternative variants of the lead and lag time TTO","volume":"22","author":"Devlin","year":"2013","journal-title":"Health Econ"},{"key":"10.1016\/j.jval.2016.11.016_bib16","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s40273-016-0404-1","article-title":"EuroQol protocols for time trade-off valuation of health outcomes","volume":"34","author":"Oppe","year":"2016","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jval.2016.11.016_bib17","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","article-title":"Modeling valuations for EuroQol health states","volume":"35","author":"Dolan","year":"1997","journal-title":"Med Care"},{"key":"10.1016\/j.jval.2016.11.016_bib18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00005650-200503000-00003","article-title":"US valuation of the EQ-5D health states: development and testing of the D1 valuation model","volume":"43","author":"Shaw","year":"2005","journal-title":"Med Care"},{"key":"10.1016\/j.jval.2016.11.016_bib19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1478-7954-10-2","article-title":"A critical re-evaluation of the regression model specification in the US D1 EQ-5D value function","volume":"10","author":"Rand-Hendriksen","year":"2012","journal-title":"Popul Health Metr"},{"key":"10.1016\/j.jval.2016.11.016_bib20","unstructured":"R Development Core Team. R: a language and environment for statistical computing. Available from: http:\/\/www.R-project.org\/. [Accessed April 26, 2016]."},{"key":"10.1016\/j.jval.2016.11.016_bib21","author":"Pinheiro","year":"2016","journal-title":"nlme: linear and nonlinear mixed effects models."},{"key":"10.1016\/j.jval.2016.11.016_bib22","series-title":"China Guidelines for Pharmacoeconomic Evaluations and Guide","author":"Liu","year":"2015"},{"key":"10.1016\/j.jval.2016.11.016_bib23","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/01621459.1984.10478083","article-title":"Cross-validation of regression models","volume":"79","author":"Picard","year":"1984","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.jval.2016.11.016_bib24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0167-6296(01)00130-8","article-title":"The estimation of a preference-based measure of health from the SF-36","volume":"21","author":"Brazier","year":"2002","journal-title":"J Health Econ"},{"key":"10.1016\/j.jval.2016.11.016_bib25","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1177\/0272989X15601047","article-title":"Logical inconsistencies in 3 preference elicitation methods for EQ-5D health states: a study in the Brazilian population","volume":"36","author":"Andrade","year":"2016","journal-title":"Med Decis Making"},{"key":"10.1016\/j.jval.2016.11.016_bib26","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.jval.2014.05.007","article-title":"Chinese time trade-off values for EQ-5D health states","volume":"17","author":"Liu","year":"2014","journal-title":"Value Health"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301516341250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301516341250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T08:20:39Z","timestamp":1536049239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301516341250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1098301516341250"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2016.11.016","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimating an EQ-5D-5L Value Set for China","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2016.11.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}